3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Dermatologic
1
Conditions
Skin Neoplasms
1
Multiple Sclerosis, Relapsing-Remitting
1
Multiple Sclerosis
1
Melanoma
1
Carcinoma, Basal Cell
1
Interventions
HhAntag691
14
Biopsy
8
Imiquimod
7
Aminolevulinic Acid
7
sonidegib
6
Tomography, Optical Coherence
6
Surgical Procedures, Operative
6
Photochemotherapy
6
Mohs Surgery
6
1-phenyl-3,3-dimethyltriazene
6
Radiotherapy
5
Itraconazole
5
Nivolumab
4
Microscopy, Confocal
4
Curettage
4
pembrolizumab
3
methyl 5-aminolevulinate
3
cemiplimab
3
Standard of Care
3
Niacinamide
3
tazarotene
2
relatlimab
2
X-Rays
2
Watchful Waiting
2
Specimen Handling
2
Observation
2
Magnetic Resonance Spectroscopy
2
Laser Therapy
2
Gene Expression Profiling
2
Eflornithine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Carcinoma, Basal Cell
×
teriflunomide
×
Clear all
NCT06705608
2024-11-26
MS; FTY720
University of British Columbia
Completed
4,000 enrolled